CLINICAL ROLE -
Patient Assistance Programs: The Good, the Bad, and the Ugly
For many years, employers, payers, and pharmacy benefit managers have been developing benefit designs to incentivize patients and providers to make cost-effective treatment decisions.
Patient Assistance Programs Are the Good, the Bad, and the Ugly
Maximizer programs are likely to lead to the dwindling or death of PAPs as we know them.
Supportive Care Is "Doing Something"
Pharmacists should be vocal in objecting to unproven therapies for COVID-19 being widely used primarily based on wishful thinking.
Here Are Some Lessons Learned During the Pandemic
Consider these 5 takeaways from a pharmacy leader in an academic health care system during the COVID-19 crisis.
Better (and Faster) Hoarding Wins
A more reasonable way to address shortages: price drugs at a level that provides incentive to ensure a consistent, high-quality supply.
API Sourcing: Is This Really a Good Idea?
Health System Pharmacists Should Think About the Implications of Acquiring and Dispensing These Compounded Products.
2 Clarke Drive Cranbury, NJ 08512